Elevation of plasma interleukin-18 concentration is associated with insulin levels in patients with systemic lupus erythematosus

Tim K. Tso, W. N. Huang, H. Y. Huang, C. K. Chang

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We previously reported that systemic lupus erythematosus (SLE) patients have a higher risk of insulin resistance and abnormal insulin secretion. Recent studies demonstrated that interleukin (IL)-18, a novel pro-inflammatory cytokine, may be involved in triggering the inflammatory processes in SLE and the concentrations of circulating IL-18 in SLE patients were significantly higher than those in healthy subjects. IL-12 has a synergistic effect with IL-18, and both cytokines are inducers of interferon (IFN)-γ. The objective of this study was to identify the effect of fasting insulin levels on circulating concentrations of IL-18, IL-12 and IFN-γ in patients with SLE. Plasma levels of proinflammatory Th-1 cytokines were determined by enzyme-linked immunosorbent assay in a total of 70 female SLE patients and 34 age-matched healthy females. Insulin resistance (IR) and secretion were evaluated by homeostasis model assessment (HOMA). All patients were further classified into subgroups based on the quartiles of fasting insulin levels. SLE patients with fasting insulin levels in the top quartile compared with other quartiles had significantly higher plasma levels of IL-18. The presence of insulin auto-antibodies (IAA) in SLE patients had no influence on plasma levels of IL-18. In addition, fasting insulin levels and HOMA IR were positively correlated with IL-18 in all SLE patients, respectively. In conclusion, elevated circulating IL-18 concentrations corresponded with increases in fasting insulin levels and the status of insulin resistance in patients with SLE.

Original languageEnglish
Pages (from-to)207-212
Number of pages6
JournalLupus
Volume15
Issue number4
DOIs
Publication statusPublished - May 10 2006
Externally publishedYes

Fingerprint

Interleukin-18
Systemic Lupus Erythematosus
Insulin
Fasting
Insulin Resistance
Interleukin-12
Cytokines
Homeostasis
Interferon Inducers
Insulin Antibodies
Interferons
Healthy Volunteers
Enzyme-Linked Immunosorbent Assay

Keywords

  • Insulin
  • Interferon-γ
  • Interleukin-12
  • Interleukin-18
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Rheumatology

Cite this

Elevation of plasma interleukin-18 concentration is associated with insulin levels in patients with systemic lupus erythematosus. / Tso, Tim K.; Huang, W. N.; Huang, H. Y.; Chang, C. K.

In: Lupus, Vol. 15, No. 4, 10.05.2006, p. 207-212.

Research output: Contribution to journalArticle

@article{da167997e66c4319892fda63df505ad4,
title = "Elevation of plasma interleukin-18 concentration is associated with insulin levels in patients with systemic lupus erythematosus",
abstract = "We previously reported that systemic lupus erythematosus (SLE) patients have a higher risk of insulin resistance and abnormal insulin secretion. Recent studies demonstrated that interleukin (IL)-18, a novel pro-inflammatory cytokine, may be involved in triggering the inflammatory processes in SLE and the concentrations of circulating IL-18 in SLE patients were significantly higher than those in healthy subjects. IL-12 has a synergistic effect with IL-18, and both cytokines are inducers of interferon (IFN)-γ. The objective of this study was to identify the effect of fasting insulin levels on circulating concentrations of IL-18, IL-12 and IFN-γ in patients with SLE. Plasma levels of proinflammatory Th-1 cytokines were determined by enzyme-linked immunosorbent assay in a total of 70 female SLE patients and 34 age-matched healthy females. Insulin resistance (IR) and secretion were evaluated by homeostasis model assessment (HOMA). All patients were further classified into subgroups based on the quartiles of fasting insulin levels. SLE patients with fasting insulin levels in the top quartile compared with other quartiles had significantly higher plasma levels of IL-18. The presence of insulin auto-antibodies (IAA) in SLE patients had no influence on plasma levels of IL-18. In addition, fasting insulin levels and HOMA IR were positively correlated with IL-18 in all SLE patients, respectively. In conclusion, elevated circulating IL-18 concentrations corresponded with increases in fasting insulin levels and the status of insulin resistance in patients with SLE.",
keywords = "Insulin, Interferon-γ, Interleukin-12, Interleukin-18, Systemic lupus erythematosus",
author = "Tso, {Tim K.} and Huang, {W. N.} and Huang, {H. Y.} and Chang, {C. K.}",
year = "2006",
month = "5",
day = "10",
doi = "10.1191/0961203306lu2284oa",
language = "English",
volume = "15",
pages = "207--212",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - Elevation of plasma interleukin-18 concentration is associated with insulin levels in patients with systemic lupus erythematosus

AU - Tso, Tim K.

AU - Huang, W. N.

AU - Huang, H. Y.

AU - Chang, C. K.

PY - 2006/5/10

Y1 - 2006/5/10

N2 - We previously reported that systemic lupus erythematosus (SLE) patients have a higher risk of insulin resistance and abnormal insulin secretion. Recent studies demonstrated that interleukin (IL)-18, a novel pro-inflammatory cytokine, may be involved in triggering the inflammatory processes in SLE and the concentrations of circulating IL-18 in SLE patients were significantly higher than those in healthy subjects. IL-12 has a synergistic effect with IL-18, and both cytokines are inducers of interferon (IFN)-γ. The objective of this study was to identify the effect of fasting insulin levels on circulating concentrations of IL-18, IL-12 and IFN-γ in patients with SLE. Plasma levels of proinflammatory Th-1 cytokines were determined by enzyme-linked immunosorbent assay in a total of 70 female SLE patients and 34 age-matched healthy females. Insulin resistance (IR) and secretion were evaluated by homeostasis model assessment (HOMA). All patients were further classified into subgroups based on the quartiles of fasting insulin levels. SLE patients with fasting insulin levels in the top quartile compared with other quartiles had significantly higher plasma levels of IL-18. The presence of insulin auto-antibodies (IAA) in SLE patients had no influence on plasma levels of IL-18. In addition, fasting insulin levels and HOMA IR were positively correlated with IL-18 in all SLE patients, respectively. In conclusion, elevated circulating IL-18 concentrations corresponded with increases in fasting insulin levels and the status of insulin resistance in patients with SLE.

AB - We previously reported that systemic lupus erythematosus (SLE) patients have a higher risk of insulin resistance and abnormal insulin secretion. Recent studies demonstrated that interleukin (IL)-18, a novel pro-inflammatory cytokine, may be involved in triggering the inflammatory processes in SLE and the concentrations of circulating IL-18 in SLE patients were significantly higher than those in healthy subjects. IL-12 has a synergistic effect with IL-18, and both cytokines are inducers of interferon (IFN)-γ. The objective of this study was to identify the effect of fasting insulin levels on circulating concentrations of IL-18, IL-12 and IFN-γ in patients with SLE. Plasma levels of proinflammatory Th-1 cytokines were determined by enzyme-linked immunosorbent assay in a total of 70 female SLE patients and 34 age-matched healthy females. Insulin resistance (IR) and secretion were evaluated by homeostasis model assessment (HOMA). All patients were further classified into subgroups based on the quartiles of fasting insulin levels. SLE patients with fasting insulin levels in the top quartile compared with other quartiles had significantly higher plasma levels of IL-18. The presence of insulin auto-antibodies (IAA) in SLE patients had no influence on plasma levels of IL-18. In addition, fasting insulin levels and HOMA IR were positively correlated with IL-18 in all SLE patients, respectively. In conclusion, elevated circulating IL-18 concentrations corresponded with increases in fasting insulin levels and the status of insulin resistance in patients with SLE.

KW - Insulin

KW - Interferon-γ

KW - Interleukin-12

KW - Interleukin-18

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=33646257345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646257345&partnerID=8YFLogxK

U2 - 10.1191/0961203306lu2284oa

DO - 10.1191/0961203306lu2284oa

M3 - Article

VL - 15

SP - 207

EP - 212

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 4

ER -